Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2004
03/16/2004US6706475 Oligonucleotide probes for detecting Enterobacteriaceae and quinolone-resistant Enterobacteriaceae
03/11/2004WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof
03/11/2004WO2004020968A2 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
03/11/2004WO2004020675A2 Polymorphism detection among homologous sequences
03/11/2004WO2004020654A2 Solid phase based nucleic acid assays combining high affinity and high specificity
03/11/2004WO2004020625A1 SELECTION AND ISOLATION OF LIVING CELLS USING mRNA-BINDING PROBES
03/11/2004WO2004020602A2 Terminal phosphate blocked nucleoside polyphosphates
03/11/2004WO2004020451A1 Group b streptococcal phage lysin
03/11/2004WO2004020450A1 Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof
03/11/2004WO2004020449A1 Process for separating and deprotecting oligonucleotides
03/11/2004WO2004020404A2 Modified transferin-antibody fusion proteins
03/11/2004WO2004019893A2 Modulators of angiogenesis
03/11/2004WO2003064993A3 Methods and materials for detecting genetic material
03/11/2004WO2003059155A3 Method of detecting t-cell proliferation for diagnosis of diseases by gene array
03/11/2004WO2003014306A3 Antisense modulation of cholesteryl ester transfer protein expression
03/11/2004WO2002083709A3 Kinases and phosphatases
03/11/2004WO2002079441A3 Secreted proteins
03/11/2004WO2002060923A3 B-superfamily conotoxins
03/11/2004US20040049810 Maize gene dull1 (du1) is a determinant of the structure of endosperm starch
03/11/2004US20040049807 A pathway for defense responses in plants, and genes involved in that pathway
03/11/2004US20040049803 Metallothionein (MTI) and glutamine synthatase (GS) promoters capable of promoting the senescence-associated expression of nucleic acid coding sequences
03/11/2004US20040049024 Compositions and methods related to the minn1 tumor suppressor gene and protein
03/11/2004US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty
03/11/2004US20040049021 Compositions and mehtods for treatment of Hepatitis C virus-associated diseases
03/11/2004US20040049010 Transmembrane proteins
03/11/2004US20040049008 Templated molecules and methods for using such molecules
03/11/2004US20040048826 Oligonucleotides containing 2'-0-modified purines
03/11/2004US20040048821 Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene
03/11/2004US20040048820 Prevention or therapy of cardiovascular complications
03/11/2004US20040048818 Antisense modulation of e2f transcription factor 2 expression
03/11/2004US20040048817 Methods of immunotherapy and diagnosis
03/11/2004US20040048396 Facilitating an activity determination for gel-based/ chromatographic-based endpoint or dose response analysis
03/11/2004US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics
03/11/2004US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/11/2004US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/11/2004US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells
03/11/2004US20040048310 For diagnosis/therapy central nervous/psychological disorders
03/11/2004US20040048309 DNA from thermophilic bacterium; chromosomal replicases
03/11/2004US20040048295 Screening methods for identifying agonists and antagonists of hereulin -like factor (HLF) activity; diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation
03/11/2004US20040048290 Aminoacyl trna synthetases
03/11/2004US20040048269 Used in the diagnosis, treatment, and prevention of cancer, neurological disorders, autoimmune/inflammatory disorders, gastrointestinal disorders, and cardiovascular disorders
03/11/2004US20040048267 Novel calpastatin (CAST) alleles
03/11/2004US20040048261 Of given sequence; hybridization; culturing a Drosophila cell to express the gene; use in identifying pesticides
03/11/2004US20040048255 Peptide of given amino acid sequence; identifying molecules that bind to and modulate the protease
03/11/2004US20040048253 Isolated polynucleotide of given sequence; detecting it in a sample by polymerase chain reaction amplification; screening compounds for toxicity and effectivenss in altering expression
03/11/2004US20040048252 PCR(Polymerase chain reaction); protecting groups; cross-linking of free ends which are easily accessible for appropriate enzymatic activity
03/11/2004US20040048251 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer
03/11/2004US20040048250 ATP-binding cassette (abc-1); isolated and purified DNA sequence; use in treating or preventing epilepsy and dyslipidemia-related syndromes
03/11/2004US20040048244 Extracellular signaling molecules
03/11/2004US20040048240 Submergence-induced protein-like factors
03/11/2004US20040047931 Composition and method to whiten skin
03/11/2004US20040047854 New disintegrin polypeptide, methods of making such polypeptides, and methods of using them to treat disintegrin-associated disorders and conditions and to identify agents that modulate Metalloproteinase-Disintegrin
03/11/2004US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease
03/11/2004US20040047808 Method of treating cystic fibrosis in a human subject diagnosed with cystic fibrosis, comprising administering to the subject, in a pharmaceutically acceptable carrier, an effective amount of a fusion protein, comprising a cystic
03/11/2004DE10240417A1 Decoy-Oligonukleotid-Hemmung der CD40-Expression Decoy Oligonucleotide inhibition of CD40 expression
03/11/2004DE10237704A1 Verfahren und Vorrichtung zum intermolekularen Transfer von Aktivierungsenergie zur Bindungsspaltung durch den Raum Method and apparatus for intermolecular transfer of activation energy to the bond cleavage through the space
03/11/2004DE10237393A1 Determining risk of developing arteriosclerosis or coronary artery disease, by detecting both polymorphisms in the mbl2 gene and infection by Chlamydia pneumoniae
03/11/2004CA2497597A1 Methods for identifying subjects at risk of melanoma and treatments
03/11/2004CA2497297A1 Solid phase based nucleic acid assays combining high affinity and high specificity
03/11/2004CA2495295A1 Group b streptococcal phage lysin
03/11/2004CA2495207A1 Modified transferin-antibody fusion proteins
03/11/2004CA2494150A1 Process for separating and deprotecting oligonucleotides
03/10/2004EP1396542A2 Novel P-selectin ligand protein
03/10/2004EP1395679A2 Nucleotide carrier for diagnosing and treating oral diseases
03/10/2004EP1395669A2 Matrix attachment regions and methods for use thereof
03/10/2004EP1395600A2 Products containing charged biomaterials and method for the preparation thereof
03/10/2004EP1005572A4 Solid support with attached molecules
03/10/2004EP0771360B1 Method for the detection of the antibiotic resistance spectrum of mycobacterium species
03/10/2004EP0762894B1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
03/10/2004CN1481442A Novel primers for screening schizop hrenia and method thereof
03/10/2004CN1480531A Method for purifying plasmid
03/10/2004CN1141390C Whole genome sequence of YN87448 virus strain and its cloning method
03/10/2004CN1141316C Gene sequence of genital regulation factor enriched in hypothalamus of epinephelus and its usage
03/10/2004CN1141315C Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application
03/09/2004US6703487 Polypeptide for use in the treatment of rheumatoid arthritis, myeloma, osteoporosis, endotoxemia, sepsis, osteoarthritis, inflammatory bowel disease and allergy
03/09/2004US6703374 Activated by thymidylate synthase and/or thymidine kinase enzyme; antitumor agents; diagnosis
03/09/2004US6703197 Human methionine synthase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer
03/04/2004WO2004019002A2 Fluorescent glycosides and methods for their use
03/04/2004WO2004019001A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
03/04/2004WO2004018695A2 Method for producing ketocarotinoids in plant fruit
03/04/2004WO2004018694A2 Method for producing ketocarotinoids in genetically modified organisms
03/04/2004WO2004018693A2 Method for the production of ketocarotinoids in flower petals on plants
03/04/2004WO2004018689A1 Anti-neoplastic viruses
03/04/2004WO2004018666A1 Expression vectors encoding epitopes of target-associated antigens
03/04/2004WO2004018665A1 Nucleic acid recovery chip and nucleic acid recovery device
03/04/2004WO2004018664A1 Nucleic acid analysis chip and nucleic acid analyzer
03/04/2004WO2004018626A2 Abasic site endonuclease assay
03/04/2004WO2004018620A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter
03/04/2004WO2004018499A2 Synthetic heparin-binding growth factor analogs
03/04/2004WO2004018497A2 Modified nucleotides for polynucleotide sequencing
03/04/2004WO2004018493A1 Labelled nucleotides
03/04/2004WO2004018385A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
03/04/2004WO2004017926A2 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
03/04/2004WO2004017909A2 Methods of reducing ischemic injury
03/04/2004WO2004017749A2 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
03/04/2004WO2004005554A3 Antisense modulation of livin expression
03/04/2004WO2003106674A3 Use of repression blocking sequences in methods for enhancing gene expression
03/04/2004WO2003070941A3 Method for the identification of tissue-specific regulatory sequences
03/04/2004WO2003044211A3 Materials and methods for releasing genetic material
03/04/2004WO2003040409A9 Novel germinal center kinase proteins, compositions, and methods of use